Yishai Ofran

21PUBLICATIONS
80CO-AUTHORS
Medical mycologyGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|May 07, 2025
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.

Amy E DeZern, Sylvain Thepot, Stephane de Botton

|Dec 25, 2024
CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot study.

Chezi Ganzel, Avraham Frisch, Ofir Wolach

|Dec 05, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study.

Ofir Wolach, Itai Levi, Boaz Nachmias

|May 23, 2024
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.

Eitan Kugler, Inbar Cohen, Irina Amitai

|May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.

Jonathan Canaani, Avraham Frisch, Daniel A Pollyea

Pageof 4

Frequent Collaborators

8 joint publications

Chezi Ganzel

4 joint publications

Ofir Wolach

3 joint publications

Jacob M Rowe

2 joint publications

Tsila Zuckerman